Beta-keto amide intermediate synthesis for E6020 precursor
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing immunological adjuvants like E6020 are inefficient, and there is a need for improved synthetic processes that involve new intermediates and reactions to enhance the production of TLR-4 receptor agonists for use in vaccines.
Innovation Solution
A new synthesis method for E6020 precursor Compound 26 is developed via a β-keto amide intermediate Compound 22, involving specific reaction steps and intermediates, including the preparation of β-keto amide alcohol and urea di-phosphoramidite compounds, which allows for the production of crystalline forms that improve purification and yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current synthesis methods are used for E6020 precursor, then the synthesis process is established, but the process is inefficient and requires additional purification steps
Solution Approach 1:
The patent applies parameter changes by modifying the synthetic route to use a β-keto amide intermediate (Compound 22) with specific crystalline forms. This changes the physical and chemical parameters of the intermediate, enabling it to crystallize in a form that facilitates easier purification and reduces the number of purification steps required while maintaining high synthesis efficiency.
Solution Approach 2:
The patent introduces a β-keto amide intermediate (Compound 22) as a mediator in the synthesis pathway. This intermediate serves as a bridge between the starting materials and the final E6020 precursor, allowing for controlled reaction steps and simplified purification. The intermediate's crystalline form enables selective isolation and purification without requiring complex multi-step purification processes.
2Productivity
If current synthesis methods are used for E6020 precursor, then the synthesis can proceed, but the yield is reduced and cost-effectiveness is lowered
Solution Approach 1:
The patent changes the synthetic parameters by employing a specific β-keto amide intermediate formulation that crystallizes in a favorable form. This parameter change directly impacts the reaction yield and reduces material loss during purification, thereby improving both productivity and cost-effectiveness of the manufacturing process.
Solution Approach 2:
The β-keto amide intermediate acts as a mediator that improves the overall yield of the synthesis process. By providing a stable, crystalline intermediate form, the patent enables more efficient material utilization and reduces waste, leading to higher yields and improved cost-effectiveness without compromising manufacturing ease.
3Productivity
If new synthesis method with β-keto amide intermediate is used, then purification steps are reduced and yield increases, but new intermediates and reactions must be developed
Solution Approach 1:
The patent applies parameter changes by selecting and optimizing the β-keto amide intermediate's crystalline form. This specific parameter optimization allows the intermediate to be easily isolated and purified through crystallization, reducing the need for additional purification steps while maintaining a manageable synthetic pathway.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enhances the synthesis of E6020 by reducing the need for additional purification steps, increasing yield, and providing a high-purity intermediate, thus making the process more cost-effective and efficient.
Implementation Method 1
condensation of the β-keto amide (3) with a urea di-phosphoramidite (4)
Data Source
Figure 1
Figure 2
Figure 3
AI summary
This invention relates to the synthesis for a precursor of E6020, compound 26, via a β-keto amide alcohol intermediate, compound 22, The synthesis reacts compound 22 with compound 25 and the resultant intermediate is oxidized to produce compound 26, the precursor to E6020. Compounds 22 and 25, and their crystalline forms, represent separate embodiments of the invention. The invention also relates to compounds of formulas (3) and (4) and processes for their preparation. The β-keto amide alcohol intermediate compound 22 is a compound of formula (3). Compound 25 is a compound of formula (4).